gut.bmj3d
ECM1 attenuates hepatic fibrosis by interfering with mediators of latent TGF-β1 activation
Objective Extracellular matrix protein 1 (ECM1) serves as a gatekeeper of hepatic fibrosis by maintaining transforming growth ...
gut.bmj1d
Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
gut.bmj2d
Diagnosis and management of acute lower gastrointestinal bleeding: guidelines from the British Society of Gastroenterology
Correspondence to Dr Jonathan Hoare, Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK; j.hoare{at}ic.ac.uk This is the first UK national guideline to concentrate on ...
gut.bmj1d
Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome
Visceral hypersensitivity has been recognised as a characteristic of patients with irritable bowel syndrome (IBS). It may be involved in the pathogenesis of abdominal pain/discomfort, and seems to ...
gut.bmj3d
Guidelines for follow up after resection of colorectal cancer
Correspondence to: Professor J H Scholefield, Department of Surgery, University Hospital, Nottingham NG7 2UH, UK; john.scholefield{at}nottingham.ac.uk Follow up after colorectal resection is a ...
gut.bmj1d
Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis
Correspondence to Dr Thomas Berg, Section of Hepatology, Department of Internal Medicine, University Hospital Leipzig, Leipzig 04103, Germany; thomas.berg{at}medizin.uni-leipzig.de Objective ...
gut.bmj1d
Anthranoid laxative abuse--a risk for colorectal cancer?
Anthranoid-containing laxatives--aloe, cascara, frangula, and rheum--may play a role in colorectal cancer. This risk is particularly important in view of the wide abuse of self administered laxatives ...
gut.bmj4d
Nerve growth factor and Trk high affinity receptor (TrkA) gene expression in inflammatory bowel disease
Dr Helmut Friess, Department of Visceral and Transplantation Surgery, University of Bern, Inselspital, CH-3010 Bern, Switzerland. Email: helmut.friess{at}insel.ch BACKGROUND Nerve growth factor (NGF), ...
gut.bmj5d
Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease
Professor J P Galmiche, Centre de Recherche en Nutrition Humaine, CRI INSERM 95-08, CHU, Hôtel Dieu, Place A Ricordeau, 44035 Nantes cedex 01, France. Email:galmiche{at}easynet.fr BACKGROUND/AIM ...
gut.bmj6d
Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions
Correspondence to Wouter J den Hollander, Department of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam 3000 CA, The Netherlands; w.j.denhollander{at}gmail.com Objective ...
gut.bmj1d
An evidence-based appraisal of reflux disease management — the Genval Workshop Report
aDepartment of Gastrointestinal Medicine, Royal Adelaide Hospital, Adelaide, Australia, bSödra Hõlsocentralen, Hudiksvall, Sweden, cUniversity of Michigan Health ...